NasdaqHealth CareSurgical & Medical Instruments & ApparatusIRVINE, CA

enVVeno Medical Corporation NVNO

Ask your AI

Estimated market cap $4.29M694,826 shares, shares as of Oct 27, 2026CIK 1661053

Insider trades, 12 mo

0 buys · 4 sells

$4,944 sold, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

5.1% of shares · 2 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in enVVeno Medical Corporation's latest quarterly report, compared with the one before.

Filed Oct 29, 2026 · Quarter ended Sep 30, 2026

AI No AI summary for this 10-Q: the draft did not pass our accuracy checks.

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in enVVeno Medical Corporation's latest quarterly report, compared with the one before.

Loading…

Insider trades

4 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Sep 11, 2026. Insiders have two business days to file.

Recent insider trades

Francis Duhay Director	Sep 11 Form 4 ↗	Sale 10b5-1 plan	−$123 11 sh @ $11.21	-39.9%
Francis Duhay Director	Jun 11 Form 4 ↗	Sale 10b5-1 plan	−$1,443 140 sh @ $10.31	-41.9%
Francis Duhay Director	Mar 12 Form 4 ↗	Sale 10b5-1 plan	−$1,613 140 sh @ $11.52	-57.2%
Francis Duhay Director	Dec 11, 2025 Form 4 ↗	Sale 10b5-1 plan	−$1,764 4,900 sh @ $0.36	-59.4%
Francis Duhay Director	Sep 15, 2025 Form 4 ↗	Sale 10b5-1 plan	−$4,067 4,900 sh @ $0.83	-94.7%

All NVNO insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

35,421 shares

13 funds report NVNO. Values checked against market prices.

Funds own 13% of shares (Q2 2026)

17 funds hold the stock.

Q3 2026: 5.1% · 5,560 of ~8,900 funds reported so far

Q1 202615%
Q2 202613%
Q3 2026 (so far)5.1%

Q3 2026. 1 new, 2 added to, 1 trimmed, 5 exited since Q2 2026.

Top 13F holders
#
1	CM Management, LLC 13F ↗	17,142	$133.7K	-52.0%
2	Vanguard Capital Management LLC 13F ↗	6,287	$53.2K	unchanged
3	JPMorgan Chase & Co 13F ↗	5,219	$44.0K	+0.2%
4	Vanguard Fiduciary Trust Co 13F ↗	2,184	$18.5K	unchanged
5	UBS Group AG 13F ↗	1,965	$15.3K	+196400.0%
6	Westside Investment Management, Inc. 13F ↗	1,525	$11.9K	unchanged
7	Mirae Asset Global Investments Co., Ltd. 13F ↗	539	$4,204	unchanged
8	BlackRock, Inc. 13F ↗	414	$3,229	unchanged
9	Vanguard Global Advisers, LLC 13F ↗	77	$651	unchanged
10	Morgan Stanley 13F ↗	59	$460	unchanged

Download CSV Every fund that holds NVNO, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What enVVeno Medical Corporation and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What enVVeno Medical Corporation and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q1 2026	17	—	100,508	$1.0M
Q2 2026	17	0	88,718	$953.6K
Q3 2026	13	-4	35,421	$285.3K

Each point is a quarter-end, from Q1 2026 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (29415J205). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q1 2026) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes11 in 12 mo 8-K eventsNone in 90 days Patents4 patents granted Short interestFINRA · updated Oct 15 Planned insider salesForm 144 · 3 in 12 mo Executive pay1 fiscal year Wikipedia attentionNone on record SEC enforcementNone on record IPO history9 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: enVVeno Medical Corp
Address: 70 DOPPLER, IRVINE, CA 92618
Phone: 949-261-2900
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company
Incorporated in: DE
Listed as: NVNO (Nasdaq)
Former names: Hancock Jaffe Laboratories, Inc. (until 2021)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$6.17−$0.41 (−6.16%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $6.17 · High $7.97Nov 13, 2026

Aug 13, 2026Low $6.17 · High $11.80Nov 13, 2026

Nov 13, 2025Low $6.17 · High $22.86Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. The stock split 1-for-35 on Jan 20, 2026; earlier prices are shown divided by the split ratio. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.